Standard Nuclear slashes IPO plans to 10 million shares By Investing.com

Standard Nuclear (NYSE: STDN) rose after multiple brokerages initiated or upgraded coverage. Analysts at Barclays, Evercore ISI, and Stifel set price targets of $17 and $16. STDN also reported construction and DOE safety-analysis approvals for two TRISO fuel facilities, targeting up to 5 MTU/year additional capacity once scaled.

The Trump administration said the DOE’s Genesis Mission will fund 278 research projects, with Project Prometheus receiving a Phase II award of $60 million over three years to apply AI to nuclear reactor design. The project is led by Nvidia and AWS, with Microsoft and national labs. X-Energy, Oklo, and Standard Nuclear were named partners. Shares fell for X-Energy, Oklo, and Standard Nuclear on the day.

The Trump administration’s “Project Prometheus” under the DOE’s Genesis Mission will fund 278 research projects, with Phase II funding of $60 million over three years for the Prometheus AI nuclear effort. Partners include Nvidia, Amazon Web Services, Microsoft, and nuclear firms X-Energy, Oklo, and Standard Nuclear, plus DOE national labs. Investors may view participation as potential regulatory and commercialization support.

Standard Nuclear, Inc. priced its IPO at $15.00 per share, selling 10,000,000 Class A shares, with an underwriters’ option for up to 1,500,000 additional shares at the same price, according to a press release. Shares are expected to start trading on the NYSE under STDN on July 16, 2026, after the SEC made the registration effective July 15.

Standard Nuclear, a nuclear fuel producer, cut its planned U.S. IPO size by more than half, according to a regulatory filing. It will sell 10 million shares at $15 each, down from 18.25 million shares priced at $18 to $21. The valuation target is about $2.4 billion versus $3.55 billion. BofA and Goldman are joint lead managers; pricing is set for later Wednesday and NYSE trading Thursday.

Standard Nuclear said it plans a U.S. IPO to raise up to $383.25M, offering 18.25M Class A shares at $18.00–$21.00 each, per a regulatory filing. The company applied to list on the NYSE under ticker STDN. Underwriters include BofA Securities, Goldman Sachs, Barclays, UBS, Evercore ISI, RBC, William Blair, and Stifel.